Filing Details
- Accession Number:
- 0001209191-18-035238
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-04 17:18:47
- Reporting Period:
- 2018-06-01
- Accepted Time:
- 2018-06-04 17:18:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178879 | Amicus Therapeutics Inc | FOLD | Pharmaceutical Preparations (2834) | 200422823 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1593353 | Hung Do | C/O Amicus Therapeutics, Inc. 1 Cedar Brook Drive Cranbury NJ 08512 | Chief Science Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-06-01 | 25,000 | $16.72 | 396,771 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale of common stock was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2018.
- This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $16.49 to $17.08. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
